Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
IsraelIPO:
12 September 2014Website:
http://golifeward.comNext earnings report:
27 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 22:16:16 GMTDividend
Analysts recommendations
Institutional Ownership
LFWD Latest News
Lifeward Ltd. (NASDAQ:LFWD ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Mike Lawless – Chief Financial Officer Larry Jasinski – Chief Executive Officer Conference Call Participants Swayampakula Ramakanth – H.C.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, today announced that the Company will release its third quarter 2024 financial results before the markets open on Tuesday, November 12, 2024.
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life's passions in the face of physical limitation or disability, announced today that Mike Lawless, Chief Financial Officer, will provide an overview presentation and host one-on-one meetings with investors at the ThinkEquity Conference on October 30, 2024.
Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward's path to profitability
Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel
A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research Scientist
As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”)
Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term
ReWalk Robotics (LFWD) reported a quarterly loss of $0.73 per share, slightly higher than the Zacks Consensus Estimate of $0.70, and an increase from the loss of $0.49 per share from the same quarter last year.
ReWalk (LFWD) could see an increase in its stock price due to increasing confidence in its earnings potential, as indicated by its upgrade to a Zacks Rank #1 (Strong Buy).
What type of business is ReWalk Robotics?
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
What sector is ReWalk Robotics in?
ReWalk Robotics is in the Healthcare sector
What industry is ReWalk Robotics in?
ReWalk Robotics is in the Medical Devices industry
What country is ReWalk Robotics from?
ReWalk Robotics is headquartered in Israel
When did ReWalk Robotics go public?
ReWalk Robotics initial public offering (IPO) was on 12 September 2014
What is ReWalk Robotics website?
https://golifeward.com
Is ReWalk Robotics in the S&P 500?
No, ReWalk Robotics is not included in the S&P 500 index
Is ReWalk Robotics in the NASDAQ 100?
No, ReWalk Robotics is not included in the NASDAQ 100 index
Is ReWalk Robotics in the Dow Jones?
No, ReWalk Robotics is not included in the Dow Jones index
When was ReWalk Robotics the previous earnings report?
No data
When does ReWalk Robotics earnings report?
The next expected earnings date for ReWalk Robotics is 27 February 2025